Tuesday, March 29, 2011

Martek Biosciences plans appeal of E.U. ruling on infant formula patent - St. Louis Business Journal:

blogspot.com
That was word from the Columbia company Tuesdahy inregulatory filings. The patent office in the Hague, Netherlandsa upheld a patent that was granted to the biotec firm in 2007 but was challenged by food manufacturerwsand Ltd. The patent office said Martek’s patent applies to Martek’s nutritional oil in infangt formula, but is not covered when it is blendes with certain fish oils used ininfant formula. Martek (NASDAQ: MATK) expects the appealo will take one to two yearsx and said it does not believse the ruling will impactits revenue. Derivesd from algae, the company’s nutritionalp oils are also used in dietarty supplements andfood products, such as yogurrt and juice.
The company has been aggressivelty expanding its infant formula business overseas as it has nearly saturaterthe U.S. market. Martek warnexd in its last earnings statemen that its infant formula sales in the third and fourtuh quarters could drop as retailers trim their inventories ofthe product. The companyg anticipates demand will pick up infiscal 2010.

No comments:

Post a Comment